Skip to main content
Signal8

Galluppi Stefan

SEC insider (Form 3/4/5 filer). CIK 0001722649. Chief Innovation Officer at LifeMD, Inc. (LFMD). 6 reported Form 4/5 transactions since Sep 2024; latest on Aug 22, 2025. Located in NEW YORK, NY.

Companies Galluppi Stefan has filed insider reports for

  • LifeMD, Inc. (LFMD): Officer, Chief Innovation Officer
Galluppi Stefan profile photo

Galluppi Stefan

CIK: 0001722649

Transaction Breakdown

Open Market Buys (P)1 (16.7%)

High conviction signal

Open Market Sales (S)1 (16.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

LifeMD, Inc. logo
LFMD

LifeMD, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • LifeMD, Inc. logo
    LFMD

    LifeMD, Inc.

    Aug 22, 2025
    Award
    Direct
    30K shares-
  • LifeMD, Inc. logo
    LFMD

    LifeMD, Inc.

    Jun 13, 2025
    Sale
    Direct
    85K shares at avg. $12.38$1.1M
  • LifeMD, Inc. logo
    LFMD

    LifeMD, Inc.

    Mar 31, 2025
    Award
    Direct
    30K shares-
  • LifeMD, Inc. logo
    LFMD

    LifeMD, Inc.

    Mar 7, 2025
    Award
    Direct
    30K shares-
  • LifeMD, Inc. logo
    LFMD

    LifeMD, Inc.

    Mar 6, 2025
    Award
    Direct
    60K shares-
  • LifeMD, Inc. logo
    LFMD

    LifeMD, Inc.

    Sep 11, 2024
    Purchase
    Direct
    3K shares at avg. $4.93$15K

1-6 of 6